Literature DB >> 20508147

Signatures of RNA binding proteins globally coupled to effective microRNA target sites.

Anders Jacobsen1, Jiayu Wen, Debora S Marks, Anders Krogh.   

Abstract

MicroRNAs (miRNAs) and small interfering RNAs (siRNAs), bound to Argonaute proteins (RISC), destabilize mRNAs through base-pairing with the mRNA. However, the gene expression changes after perturbations of these small RNAs are only partially explained by predicted miRNA/siRNA targeting. Targeting may be modulated by other mRNA sequence elements such as binding sites for the hundreds of RNA binding proteins (RNA-BPs) expressed in any cell, and this aspect has not been systematically explored. Across a panel of published experiments, we systematically investigated to what extent sequence motifs in 3' untranslated regions (UTRs) correlate with expression changes following transfection of small RNAs. The most significantly overrepresented motifs in down-regulated mRNAs are two novel U-rich motifs (URMs), UUUUAAA and UUUGUUU, recently discovered as binding sites for the ELAVL4 (also known as HuD) RNA-BP. Surprisingly, the most significantly overrepresented motif in up-regulated mRNAs is the heptanucleotide AU-rich element (ARE), UAUUUAU, which is known to affect mRNA stability via at least 20 different RNA-BPs. We show that destabilization mediated by the transfected miRNA is generally attenuated by ARE motifs and augmented by URM motifs. These ARE and URM signatures were confirmed in different types of published experiments covering eight different cell lines. Finally, we show that both ARE and URM motifs couple to presumed endogenous miRNA binding sites in mRNAs bound by Argonaute proteins. This is the first systematic investigation of 3' UTR motifs that globally couple to regulation by miRNAs and may potentially antagonize or cooperate with miRNA/siRNA regulation. Our results suggest that binding sites of miRNAs and RNA-BPs should be considered in combination when interpreting and predicting miRNA regulation in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20508147      PMCID: PMC2909566          DOI: 10.1101/gr.103259.109

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  55 in total

1.  The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif.

Authors:  C Schaeffer; B Bardoni; J L Mandel; B Ehresmann; C Ehresmann; H Moine
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

2.  AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A).

Authors:  C A Lagnado; C Y Brown; G J Goodall
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

3.  A systematic analysis of intronic sequences downstream of 5' splice sites reveals a widespread role for U-rich motifs and TIA1/TIAL1 proteins in alternative splicing regulation.

Authors:  Isabel Aznarez; Yoseph Barash; Ofer Shai; David He; Julian Zielenski; Lap-Chee Tsui; John Parkinson; Brendan J Frey; Johanna M Rommens; Benjamin J Blencowe
Journal:  Genome Res       Date:  2008-05-02       Impact factor: 9.043

4.  p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

Authors:  N R Christoffersen; R Shalgi; L B Frankel; E Leucci; M Lees; M Klausen; Y Pilpel; F C Nielsen; M Oren; A H Lund
Journal:  Cell Death Differ       Date:  2009-08-21       Impact factor: 15.828

5.  The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation.

Authors:  A M Zubiaga; J G Belasco; M E Greenberg
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

6.  Fragile X-related protein and VIG associate with the RNA interference machinery.

Authors:  Amy A Caudy; Mike Myers; Gregory J Hannon; Scott M Hammond
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

7.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway.

Authors:  Peng Jin; Daniela C Zarnescu; Stephanie Ceman; Mika Nakamoto; Julie Mowrey; Thomas A Jongens; David L Nelson; Kevin Moses; Stephen T Warren
Journal:  Nat Neurosci       Date:  2004-01-04       Impact factor: 24.884

8.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments.

Authors:  Rainer Breitling; Patrick Armengaud; Anna Amtmann; Pawel Herzyk
Journal:  FEBS Lett       Date:  2004-08-27       Impact factor: 4.124

9.  Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP.

Authors:  Markus Hafner; Markus Landthaler; Lukas Burger; Mohsen Khorshid; Jean Hausser; Philipp Berninger; Andrea Rothballer; Manuel Ascano; Anna-Carina Jungkamp; Mathias Munschauer; Alexander Ulrich; Greg S Wardle; Scott Dewell; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

10.  Human MicroRNA targets.

Authors:  Bino John; Anton J Enright; Alexei Aravin; Thomas Tuschl; Chris Sander; Debora S Marks
Journal:  PLoS Biol       Date:  2004-10-05       Impact factor: 8.029

View more
  65 in total

1.  The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells.

Authors:  Michael R Epis; Andrew Barker; Keith M Giles; Dianne J Beveridge; Peter J Leedman
Journal:  J Biol Chem       Date:  2011-10-04       Impact factor: 5.157

2.  SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism.

Authors:  Lise Lotte Christensen; Kirsten True; Mark P Hamilton; Morten M Nielsen; Nkerorema D Damas; Christian K Damgaard; Halit Ongen; Emmanouil Dermitzakis; Jesper B Bramsen; Jakob S Pedersen; Anders H Lund; Søren Vang; Katrine Stribolt; Mogens R Madsen; Søren Laurberg; Sean E McGuire; Torben F Ørntoft; Claus L Andersen
Journal:  Mol Oncol       Date:  2016-06-26       Impact factor: 6.603

3.  The interplay of HuR and miR-3134 in regulation of AU rich transcriptome.

Authors:  Shivani Sharma; Suneer Verma; Madavan Vasudevan; Subhasis Samanta; Jitendra K Thakur; Ritu Kulshreshtha
Journal:  RNA Biol       Date:  2013-06-20       Impact factor: 4.652

4.  MicroRNA transfection and AGO-bound CLIP-seq data sets reveal distinct determinants of miRNA action.

Authors:  Jiayu Wen; Brian J Parker; Anders Jacobsen; Anders Krogh
Journal:  RNA       Date:  2011-03-09       Impact factor: 4.942

Review 5.  Mechanisms of dendritic mRNA transport and its role in synaptic tagging.

Authors:  Michael Doyle; Michael A Kiebler
Journal:  EMBO J       Date:  2011-08-31       Impact factor: 11.598

Review 6.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

7.  Antagonistic function of the RNA-binding protein HuR and miR-200b in post-transcriptional regulation of vascular endothelial growth factor-A expression and angiogenesis.

Authors:  Sung-Hee Chang; Yi-Chien Lu; Xi Li; Wan-Ying Hsieh; Yuquan Xiong; Mallika Ghosh; Todd Evans; Olivier Elemento; Timothy Hla
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

Review 8.  AUF1 regulation of coding and noncoding RNA.

Authors:  Elizabeth J F White; Aerielle E Matsangos; Gerald M Wilson
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-09-13       Impact factor: 9.957

9.  miR-449 inhibits cell proliferation and is down-regulated in gastric cancer.

Authors:  Tony Bou Kheir; Ewa Futoma-Kazmierczak; Anders Jacobsen; Anders Krogh; Linda Bardram; Christoffer Hother; Kirsten Grønbæk; Birgitte Federspiel; Anders H Lund; Lennart Friis-Hansen
Journal:  Mol Cancer       Date:  2011-03-18       Impact factor: 27.401

10.  The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression.

Authors:  Joshua A Azevedo; Bradley S Carter; Fan Meng; David L Turner; Manhong Dai; Alan F Schatzberg; Jack D Barchas; Edward G Jones; William E Bunney; Richard M Myers; Huda Akil; Stanley J Watson; Robert C Thompson
Journal:  J Psychiatr Res       Date:  2016-07-18       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.